AtriCure Other Current Liab vs Common Stock Analysis

ATRC Stock

USD 22.63 0.51 2.31%

AtriCure financial indicator trend analysis is way more than just evaluating AtriCure prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AtriCure is a good investment. Please check the relationship between AtriCure Other Current Liab and its Common Stock accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

Other Current Liab vs Common Stock

Other Current Liab vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AtriCure Other Current Liab account and Common Stock. At this time, the significance of the direction appears to have strong relationship.

The correlation between AtriCure's Other Current Liab and Common Stock is 0.78. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Common Stock in the same time period over historical financial statements of AtriCure, assuming nothing else is changed. The correlation between historical values of AtriCure's Other Current Liab and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of AtriCure are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Other Current Liab i.e., AtriCure's Other Current Liab and Common Stock go up and down completely randomly.

Correlation Coefficient

0.78

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Other Current Liab

Common Stock

Most indicators from AtriCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.78, whereas Enterprise Value Over EBITDA is projected to grow to (95.86).

	2021	2022	2023	2024 (projected)
Gross Profit	205.9M	245.9M	297.4M	312.3M
Total Revenue	274.3M	330.4M	399.2M	419.2M

Gross Profit Total Revenue

AtriCure fundamental ratios Correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Other Assets	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Other Current Liab	Total Current Liabilities	Accounts Payable	Cash	Inventory	Other Current Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total
Total Assets		0.96	-0.95	0.39	0.84	0.97	0.77	0.93	0.93	0.84	0.81	0.86	0.85	0.85	0.88	0.9	0.5	0.98	0.67	0.89	0.83	0.84	0.66	0.75	0.94	0.96
Total Stockholder Equity	0.96		-0.93	0.26	0.81	0.99	0.57	0.94	0.95	0.89	0.89	0.92	0.9	0.81	0.9	0.9	0.32	0.92	0.77	0.84	0.9	0.82	0.43	0.8	0.94	0.91
Retained Earnings	-0.95	-0.93		-0.27	-0.87	-0.97	-0.71	-0.94	-0.95	-0.88	-0.83	-0.89	-0.86	-0.89	-0.91	-0.92	-0.43	-0.92	-0.71	-0.84	-0.89	-0.89	-0.56	-0.79	-0.93	-0.94
Other Assets	0.39	0.26	-0.27		0.25	0.26	0.57	0.08	0.1	-0.04	0.06	0.08	0.05	0.25	0.03	0.07	0.38	0.33	-0.12	0.66	-0.06	0.23	0.63	-0.06	0.46	0.29
Common Stock Shares Outstanding	0.84	0.81	-0.87	0.25		0.83	0.71	0.76	0.77	0.68	0.58	0.65	0.63	0.99	0.76	0.78	0.51	0.84	0.45	0.7	0.68	0.99	0.52	0.51	0.74	0.8
Other Stockholder Equity	0.97	0.99	-0.97	0.26	0.83		0.62	0.96	0.97	0.91	0.89	0.93	0.91	0.84	0.92	0.92	0.35	0.93	0.77	0.85	0.92	0.85	0.48	0.82	0.95	0.94
Total Liab	0.77	0.57	-0.71	0.57	0.71	0.62		0.58	0.56	0.41	0.33	0.43	0.41	0.72	0.54	0.6	0.78	0.81	0.18	0.7	0.39	0.7	0.97	0.33	0.64	0.76
Other Current Liab	0.93	0.94	-0.94	0.08	0.76	0.96	0.58		0.99	0.95	0.91	0.95	0.95	0.78	0.92	0.92	0.29	0.9	0.81	0.75	0.95	0.79	0.44	0.89	0.9	0.92
Total Current Liabilities	0.93	0.95	-0.95	0.1	0.77	0.97	0.56	0.99		0.97	0.93	0.97	0.97	0.78	0.93	0.92	0.24	0.88	0.82	0.76	0.97	0.8	0.4	0.9	0.91	0.9
Accounts Payable	0.84	0.89	-0.88	-0.04	0.68	0.91	0.41	0.95	0.97		0.94	0.98	0.98	0.69	0.93	0.91	0.09	0.8	0.88	0.62	0.98	0.72	0.26	0.95	0.81	0.81
Cash	0.81	0.89	-0.83	0.06	0.58	0.89	0.33	0.91	0.93	0.94		0.98	0.97	0.59	0.87	0.84	-0.04	0.73	0.91	0.7	0.97	0.63	0.2	0.95	0.87	0.77
Inventory	0.86	0.92	-0.89	0.08	0.65	0.93	0.43	0.95	0.97	0.98	0.98		0.99	0.66	0.91	0.89	0.1	0.8	0.91	0.72	0.98	0.69	0.3	0.96	0.89	0.84
Other Current Assets	0.85	0.9	-0.86	0.05	0.63	0.91	0.41	0.95	0.97	0.98	0.97	0.99		0.64	0.9	0.88	0.05	0.79	0.88	0.68	0.97	0.68	0.28	0.96	0.86	0.81
Common Stock	0.85	0.81	-0.89	0.25	0.99	0.84	0.72	0.78	0.78	0.69	0.59	0.66	0.64		0.79	0.81	0.5	0.84	0.45	0.72	0.69	0.99	0.53	0.53	0.76	0.81
Property Plant Equipment	0.88	0.9	-0.91	0.03	0.76	0.92	0.54	0.92	0.93	0.93	0.87	0.91	0.9	0.79		1.0	0.27	0.87	0.79	0.65	0.93	0.8	0.4	0.89	0.81	0.87
Property Plant And Equipment Net	0.9	0.9	-0.92	0.07	0.78	0.92	0.6	0.92	0.92	0.91	0.84	0.89	0.88	0.81	1.0		0.34	0.9	0.75	0.67	0.91	0.81	0.47	0.86	0.81	0.89
Net Debt	0.5	0.32	-0.43	0.38	0.51	0.35	0.78	0.29	0.24	0.09	-0.04	0.1	0.05	0.5	0.27	0.34		0.59	-0.06	0.4	0.09	0.46	0.79	-0.02	0.31	0.6
Non Current Assets Total	0.98	0.92	-0.92	0.33	0.84	0.93	0.81	0.9	0.88	0.8	0.73	0.8	0.79	0.84	0.87	0.9	0.59		0.61	0.79	0.78	0.83	0.71	0.69	0.86	0.95
Non Currrent Assets Other	0.67	0.77	-0.71	-0.12	0.45	0.77	0.18	0.81	0.82	0.88	0.91	0.91	0.88	0.45	0.79	0.75	-0.06	0.61		0.48	0.92	0.49	0.07	0.88	0.7	0.69
Cash And Short Term Investments	0.89	0.84	-0.84	0.66	0.7	0.85	0.7	0.75	0.76	0.62	0.7	0.72	0.68	0.72	0.65	0.67	0.4	0.79	0.48		0.64	0.72	0.62	0.57	0.96	0.82
Net Receivables	0.83	0.9	-0.89	-0.06	0.68	0.92	0.39	0.95	0.97	0.98	0.97	0.98	0.97	0.69	0.93	0.91	0.09	0.78	0.92	0.64		0.72	0.23	0.95	0.83	0.83
Common Stock Total Equity	0.84	0.82	-0.89	0.23	0.99	0.85	0.7	0.79	0.8	0.72	0.63	0.69	0.68	0.99	0.8	0.81	0.46	0.83	0.49	0.72	0.72		0.51	0.58	0.77	0.81
Non Current Liabilities Total	0.66	0.43	-0.56	0.63	0.52	0.48	0.97	0.44	0.4	0.26	0.2	0.3	0.28	0.53	0.4	0.47	0.79	0.71	0.07	0.62	0.23	0.51		0.22	0.53	0.66
Property Plant And Equipment Gross	0.75	0.8	-0.79	-0.06	0.51	0.82	0.33	0.89	0.9	0.95	0.95	0.96	0.96	0.53	0.89	0.86	-0.02	0.69	0.88	0.57	0.95	0.58	0.22		0.77	0.74
Total Current Assets	0.94	0.94	-0.93	0.46	0.74	0.95	0.64	0.9	0.91	0.81	0.87	0.89	0.86	0.76	0.81	0.81	0.31	0.86	0.7	0.96	0.83	0.77	0.53	0.77		0.89
Short Long Term Debt Total	0.96	0.91	-0.94	0.29	0.8	0.94	0.76	0.92	0.9	0.81	0.77	0.84	0.81	0.81	0.87	0.89	0.6	0.95	0.69	0.82	0.83	0.81	0.66	0.74	0.89

Click cells to compare fundamentals

AtriCure Account Relationship Matchups

AtriCure fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	557.9M	714.5M	615.3M	585.4M	613.9M	644.6M
Total Stockholder Equity	247.3M	412.4M	483.8M	456.8M	466.2M	489.5M
Retained Earnings	(282.2M)	(330.4M)	(280.2M)	(326.6M)	(357.1M)	(339.2M)
Other Assets	705K	16.5M	955K	2.0M	1.0	0.95
Common Stock Shares Outstanding	37.6M	42.1M	46.0M	45.7M	46.3M	24.2M
Liabilities And Stockholders Equity	557.9M	714.5M	615.3M	585.4M	613.9M	644.6M
Other Stockholder Equity	529.7M	742.4M	764.8M	787.4M	824.2M	865.4M
Total Liab	310.5M	302.1M	131.6M	128.7M	147.8M	80.4M
Other Current Liab	32.8M	28.0M	36.1M	33.0M	44.7M	46.9M
Total Current Liabilities	49.9M	49.1M	56.4M	58.4M	74.6M	78.3M
Accounts Payable	14.9M	12.7M	18.6M	19.9M	27.4M	28.7M
Cash	28.5M	41.9M	43.7M	58.1M	84.3M	88.5M
Inventory	29.4M	35.0M	39.0M	45.9M	67.9M	71.3M
Other Current Assets	3.9M	4.3M	5.0M	5.5M	8.6M	9.0M
Common Stock	40K	45K	46K	47K	48K	28.1K
Property Plant Equipment	32.6M	28.3M	36.2M	42.6M	49.0M	51.5M
Property Plant And Equipment Net	36.7M	30.2M	36.2M	42.6M	46.8M	49.1M
Net Debt	47.9M	32.1M	32.0M	11.0M	(9.8M)	(9.3M)
Non Current Assets Total	414.7M	407.8M	419.2M	370.2M	347.7M	365.1M
Non Currrent Assets Other	705K	440K	955K	2.0M	2.2M	2.3M
Cash And Short Term Investments	81.8M	244.2M	119.1M	121.1M	137.3M	144.1M
Net Receivables	28.0M	23.1M	33.0M	42.7M	52.5M	55.1M
Common Stock Total Equity	40K	45K	46K	47K	54.1K	28.2K
Non Current Liabilities Total	260.6M	253.0M	75.1M	70.3M	73.2M	60.0M
Property Plant And Equipment Gross	36.7M	30.2M	36.2M	42.6M	99.2M	104.1M
Total Current Assets	143.2M	306.7M	196.1M	215.2M	266.2M	279.6M
Accumulated Other Comprehensive Income	(158K)	312K	(948K)	(4.1M)	(993K)	(943.4K)
Short Long Term Debt Total	76.4M	74.0M	75.6M	69.1M	74.5M	78.2M
Long Term Debt	59.6M	53.4M	59.7M	56.8M	60.6M	63.6M
Short Term Investments	53.3M	202.3M	75.4M	63.0M	53.0M	40.8M
Short Term Debt	2.2M	8.4M	1.8M	5.5M	2.5M	2.5M
Intangible Assets	129.9M	128.2M	43.0M	39.3M	64.0M	36.9M
Other Liab	186.4M	187.4M	1.2M	1.2M	1.4M	1.3M
Net Tangible Assets	(117.3M)	49.4M	206.0M	182.6M	210.0M	220.5M
Retained Earnings Total Equity	(282.2M)	(330.4M)	(280.2M)	(326.6M)	(294.0M)	(308.7M)
Long Term Debt Total	59.6M	53.4M	59.7M	56.8M	65.4M	34.9M
Capital Surpluse	529.7M	742.4M	764.8M	787.4M	905.5M	470.9M
Non Current Liabilities Other	201.0M	199.6M	15.4M	13.5M	1.2M	1.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for AtriCure Stock analysis

When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.

	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Transaction History View history of all your transactions and understand their impact on performance
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	Global Correlations Find global opportunities by holding instruments from different markets
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators

Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.80)

Revenue Per Share

8.923

Quarterly Revenue Growth

0.164

Return On Assets

(0.04)

Return On Equity

(0.08)

The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

AtriCure Other Current Liab vs Common Stock Analysis

Other Current Liab vs Common Stock

Other Current Liab vs Common Stock Correlation Analysis

Correlation Coefficient

Other Current Liab

Common Stock

AtriCure fundamental ratios Correlations

AtriCure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AtriCure fundamental ratios Accounts

Also Currently Popular

Complementary Tools for AtriCure Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Net	+ 1.0	Property Plant Equipment
Other Stockholder Equity	+ 0.99	Total Stockholder Equity
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Total Current Liabilities	+ 0.99	Other Current Liab
Other Current Assets	+ 0.99	Inventory

Other Stockholder Equity	- 0.97	Retained Earnings
Total Current Liabilities	- 0.95	Retained Earnings
Retained Earnings	- 0.95	Total Assets
Short Long Term Debt Total	- 0.94	Retained Earnings
Other Current Liab	- 0.94	Retained Earnings
Total Current Assets	- 0.93	Retained Earnings